dan ke long kang ti yao wu guo nei wai yan fa jin zhan
zhang yin chuan ;, pan yong bing ;, zhang ai hua ;

..............page:105-111

xin xi dong tai

..............page:111,115,121,127,137,143,152

zhi liao xing kang ti de duo yang hua
zuo ai dong ;

..............page:112-115

Structural characterization and comparison study of Rituxmab and its biosimilar by liquid chromatography-mass spectrometry
Li Yuan;,Qiu Jianhua;,Chen Jiaqi;,Tan Wensong;,Liang Hongyuan;,Zhao Xin;,Qu Aidong;

..............page:116-121

Construction of a human antibody DNA library and selection of anti-epidermal growth factor receptor single-chain antibodies
yu zuo ;, he yong zhi ;, cong cong ;, li kun ;, dai yun jian ;, zhang yong xia ;, he jing ;, wang ming rong ;, he ming yue ;

..............page:122-127

Advances in research on monoclonal antibodies against tumors
Sun Yan;

..............page:128-133

Study on the effect of IL-21 combined with monoclonal antibody in tumor therapy
Yue Kun;,Yang Hairui;

..............page:134-137

Research progress in autoimmune disease treatment with monoclonal antibodies against interleukin-6 and its receptor
Li ling;

..............page:138-143

Research progress and application of single domain antibody in tumor therapy
Duan Yan;

..............page:144-146,155

Research progress in human epidermal growth factor receptor 3 and tumor resistance to treatment
Peng Bo;

..............page:147-152

ying fu li xi de sheng wu lei si yao ct-p13
wang yue zhi ;, pang zhi ;

..............page:153-155

etrolizumab you dao kui yang xing jie chang yan huan jie
shi jiu hua ;

..............page:156

quan guo er tong yu fang jie zhong ri zhu ti xuan chuan huo dong

..............page:后插1-后插4